Sara E. Singer

Sara Singer practices at Adena Regional Medical Center in Chillicothe, Ohio, part of Adena Health System.

Sara Singer's NPI, 1558756031, was assigned on April 1, 2015. Sara Singer holds Ohio license 35131949.

Sara Singer's primary practice is Adena Regional Medical Center, at 272 Hospital Road, Chillicothe, OH 45601 in Ross County. The practice phone is (740) 779-7500.

Sara Singer's primary practice is Adena Regional Medical Center in Chillicothe, Ohio, part of Adena Health System. Sara Singer is also affiliated with Ohio State University Hospital. The medical group on file is Adena Health System. Dmand AI also links Sara Singer to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sara Singer practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Sara Singer's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Sara Singer is licensed in Ohio.

CMS data shows 510 Medicare services from Sara Singer across 8 procedure codes in 2024, for 201 Medicare patients. Medicare paid $25,747 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 201 Medicare patients who saw Sara Singer in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 15% are also on Medicaid. Their average risk score is 1.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sara Singer's median patient age at 73, with 54% women.

In 2024, Sara Singer wrote 969 Medicare Part D claims for 134 patients. 61% of them were for generic drugs. CMS names the drug for 783 of them, across 24 drugs with 11 or more claims each, at $2,702,953 in total drug cost. In 2023, CMS named 283 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Sara Singer for performance year 2024, reported as part of a group. Sara Singer accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Sara Singer, published from 2019 to 2020. 2019 was the busiest year, with 2. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Carmustine and Cytarabine. Sara Singer's most frequent co-authors are Don Michael Benson, MD, Yvonne A. Efebera, MD and Ashley Elizabeth Rosko, MD.

CMS Open Payments shows 18 general payments to Sara Singer from 11 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 81% of the total. Eli Lilly and Company paid the most, $100.